Sonoco (SON) Q1 2025 Earnings Call Transcript

Sonoco posted record first-quarter net sales of $1.7 billion, up 31%, with adjusted EBITDA rising 38% to $338 million and margin expanding 170 bps to 16.6%. The company completed the $1.56 billion after-tax divestiture of its thermoformed and flexible packaging business, used proceeds to repay a $1.5 billion term loan, and reduced leverage to below 4x. Management reaffirmed full-year guidance for adjusted EPS of $6.00-$6.20, ~20% sales growth to nearly $8 billion, and free cash flow of $450 million-$550 million despite industrial softness and FX headwinds.

Analysis

The important read-through is not the headline earnings beat; it is that SON has likely converted a cyclical, balance-sheet-constrained packaging story into a self-help cash compounding story. Once leverage is pulled below 4x, equity duration expands meaningfully because management can now sustain pricing, synergy capture, and dividend signaling without the market pricing in a refinancing overhang. That should mechanically compress the discount rate on the stock versus peers, especially if free cash flow lands near the midpoint of guidance and debt falls toward the 3x-3.3x target by end-2026.

The second-order winner is SON's remaining consumer packaging franchise, which now has enough scale to cross-subsidize weaker industrial volume without forcing margin-destructive behavior. The global metal platform is also more than a cost story: unified sourcing and manufacturing creates a procurement arbitrage versus smaller regional competitors that cannot re-optimize footprint as quickly, which should show up first in Europe where price-cost lagged but operating leverage is building. That implies a multi-quarter lagged margin expansion profile rather than an immediate volume-led re-rating.

The contrarian issue is that consensus may be underestimating how much of this quarter's mix benefit came from timing, not structural demand acceleration. Management's own language suggests the key near-term variables are contract resets and index pass-through, which means the next 1-2 quarters can still look noisy even if the full-year guide holds. If Europe metal volumes stay soft or North American customer destocking reappears, the market could temporarily treat the synergy narrative as over-earnings-optimized and de-rate the multiple before the second-half price actions land.

From a trade perspective, the setup favors owning equity on weakness rather than chasing strength: the stock is likely to respond best when the market sees leverage trend and synergy conversion, not the print itself. The cleanest risk/reward is a medium-term long with a catalyst calendar around second-half URB pricing realization, while using the elevated dividend yield as downside support. A sharper expression is a pair long SON versus a broader packaging/industrial basket where names without deleveraging or portfolio simplification lack the same self-help torque.

Key Decisions for Investors

• Go long SON on any post-earnings consolidation; 3-6 month horizon. Risk/reward is attractive if the market re-rates the stock on leverage trending toward sub-4x and synergy delivery, with downside cushioned by the 4.6% dividend yield.
• Add SON call spreads expiring Jan-2026 to express the second-half pricing and synergy ramp. Best if the stock is range-bound near term but free cash flow/deleveraging improves into year-end.
• Pair trade: long SON / short a diversified packaging or industrial cyclical basket over the next 2 quarters. SON has the cleaner self-help catalyst stack; the short leg should be a name without comparable balance-sheet repair or portfolio simplification.
• Use any rally that prices in flawless execution to trim 20-30% of the position; the main risk is a temporary de-rating if European volumes and customer destocking create one or two soft quarters before pricing benefits show up.
• For more tactical traders, buy SON only after the next commentary on URB index pass-through or leverage progression. Those are the two data points most likely to confirm the re-rating thesis.